Long-term therapy with cytochrome c, flavin mononucleotide and thiamine diphosphate for a patient with Kearns-Sayre syndrome
- 1 January 1996
- journal article
- case report
- Published by Elsevier in Brain & Development
- Vol. 18 (1) , 68-70
- https://doi.org/10.1016/0387-7604(95)00096-8
Abstract
No abstract availableKeywords
This publication has 10 references indexed in Scilit:
- Progressive brainstem and white matter lesions in Kearns—Sayre syndrome: a case reportBrain & Development, 1994
- Strongly succinate dehydrogenase–reactive blood vessels in muscles from patients with mitochondrial myopathy, encephalopathy, lactic acidosis, and stroke‐like episodesAnnals of Neurology, 1991
- Chronic progressive external ophthalmoplegia: A correlative study of mitochondrial DNA deletions and their phenotypic expression in muscle biopsiesJournal of the Neurological Sciences, 1990
- Long‐term coenzyme Q 10 therapy for a mitochondrial encephalomyopathy with cytochrome c oxidase deficiencyNeurology, 1989
- Treatment of Kearns‐Sayre syndrome with coenzyme Q 10Neurology, 1986
- Improvement of abnormal pyruvate metabolism and cardiac conduction defect with coenzyme Q l0 in Kearns‐Sayre syndromeNeurology, 1985
- Retinitis Pigmentosa, External Ophthalmoplegia, and Complete Heart BlockA.M.A. Archives of Ophthalmology, 1958
- Some effects of injected cytochrome C in myocardialand cerebral anoxia in manThe Journal of Pediatrics, 1946
- The Use of Cytochrome C in Combating Tissue AnoxiaScience, 1946
- SOME OBSERVATIONS ON THE EFFECT OF INJECTED CYTOCHROME C IN ANIMALS 1Journal of Clinical Investigation, 1945